Home Pilots Mark Cuban Cost Plus Drug Company partners with pharma company, COPD Foundation Pilots Mark Cuban Cost Plus Drug Company partners with pharma company, COPD Foundation By - September 6, 2023 27 0 Facebook Twitter Pinterest WhatsApp The collaborators will improve access to Tiotropium Bromide Inhalation Powder in the U.S. for patients with COPD. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Q&A: AppliedVR on building reimbursement for virtual reality therapeutics Pilots - April 3, 2023 0 AI-enabled brain imaging company icometrix receives CPT III code Pilots - July 3, 2023 0 Outpatient telehealth use declines, but is still elevated from pre-pandemic era Pilots - February 15, 2022 0 Augmedix stock falls 41% after it lowers FY24 revenue guidance Pilots - May 14, 2024 0 Lokavant raises $21M for clinical trial data platform Pilots - December 7, 2022 0 POPULAR CATEGORIESPilots2166Applications682Testing237Collaborations15GitHub3